Last reviewed · How we verify

NCT03953391

The Effect of Tea Breaks on Cerebrovascular Perfusion During Desk Work

Completed NA Last updated 7 August 2019
What this trial tests

NA trial testing Tea in Cerebrovascular Circulation in 20 participants. Completed in 15 July 2019.

Timeline
30 April 2019
Primary endpoint
24 June 2019
15 July 2019

Quick facts

Lead sponsorUnilever R&D
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment20
Start date30 April 2019
Primary completion24 June 2019
Estimated completion15 July 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Unilever R&D — full company profile →

Who can join

Adults 18 to 60, any sex, with Cerebrovascular Circulation or Affect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sedentary behaviour of healthy subjects may have a detrimental impact on cerebral blood flow as well as cognitive measures related to mood and alertness. In this study we focus on the impact of leaving the desk to consume a cup of tea at regular intervals during a sedentary working day.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tea

Trials testing the same drug.

Other recruiting trials for Cerebrovascular Circulation

Currently open trials in the same condition.

Other Unilever R&D trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03953391.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing